Scholarlink

<p>The indications for treatment with a&#xa0;cochlear implant (CI) have steadily expanded over the years. While the CI was originally designed for deaf adults, the range of indications now also includes patients with profound uni- or bilateral sensorineural hearing loss, unilateral deafness, or residual hearing. Infants and toddlers are also fitted, preferably before the age of 1&#xa0;year, in order to create optimal conditions for language development. New developments such as gene therapy for otoferlin mutations or CI treatment for vestibular schwannomas further expand the treatment options. The indication is determined individually for each ear, taking audiological, imaging, psychosocial, and cognitive factors into account. The current S2k guideline of the Association of the Scientific Medical Societies in Germany (AWMF) aims to promote high-quality care and emphasizes the importance of interprofessional collaboration in the diagnostic and care process.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Aktuelle Indikationen zur Cochlea-Implantat Versorgung

  • 期刊论文

  • 发表日期：

    2026年2月20日

查看全文
  • Till F. Jakob,
  • Antje Aschendorff,
  • Manuel C. Ketterer,
  • Rainer L. Beck,
  • Stefanie Kröger,
  • Thomas Wesarg,
  • Susan Arndt

摘要

The indications for treatment with a cochlear implant (CI) have steadily expanded over the years. While the CI was originally designed for deaf adults, the range of indications now also includes patients with profound uni- or bilateral sensorineural hearing loss, unilateral deafness, or residual hearing. Infants and toddlers are also fitted, preferably before the age of 1 year, in order to create optimal conditions for language development. New developments such as gene therapy for otoferlin mutations or CI treatment for vestibular schwannomas further expand the treatment options. The indication is determined individually for each ear, taking audiological, imaging, psychosocial, and cognitive factors into account. The current S2k guideline of the Association of the Scientific Medical Societies in Germany (AWMF) aims to promote high-quality care and emphasizes the importance of interprofessional collaboration in the diagnostic and care process.